C. Brambilla (Grenoble, France), E. Danila (Vilnius, Lithuania)
Relationship between mutated P53 and the acquired multi-drug resistance after cisplatin selection in NCI-H460 cell line of human large cell lung cancer
T. Wang, N. Zhong, J. Xu (Guangzhou, China)
|   |
Activation of CD40-CD40L signal could enhance the sensitivity of chemotherapy to lung cancer
J. A. Huang, T. L. Wang, G. H. Yu, W. Lei, X. G. Zhang (Suzhou, China)
| |
Expression of A Disintegrin and Metalloprotease (ADAM) enzymes in human squamous cell lung carcinomas
N. Rocks, M. Polette, M. M. Gueders, C. Munaut, J. M. Foidart, A. Noel, P. Birembaut, D. D. Cataldo (Liege, Belgium; Reims, France)
| |
Anti-endocan antibodies reduces tumor growth in a mouse subcutaneous xenograft model
B. D. Grigoriu, F. Depontieu, A. Scherpereel, C. H. Marquette, J. J. Lafitte, A. B. Tonnel, A. Janin, P. Lassalle (Iasi, Romania; Lille, Paris, Loos, France)
| |
Tailored therapy for non-small cell lung cancer – it is difficult to get enough good quality mRNA from bronchoscopic biopsies
K. Laule-Kilian, L. Bubendorf, M. Pless, M. Mirlacher, M. Tamm, M. H. Brutsche (Basle, Switzerland)
| |
Tissue inhibitor of metalloproteinase 3 inhibits growth of lung cancer tumours in nude mice
K. M. Finan, G. Hodge, A. M. Reynolds, A. H. Baker, P. N. Reynolds (Adelaide, Australia; Glasgow, United Kingdom)
| |
c-erbB-1 and c-erbB-2 receptors genetic abnormalities and protein expression in lung cancer
A. P. Meert, B. Martin, S. Noël, J. M. Verdebout, V. Ninane, J. P. Sculier (Brussels, Belgium)
| |
Quantification of free RNA in serum and bronchial lavage - a new tool for lung cancer detection?
B. Schmidt, E. Engel, T. Crstensen, U. Liebers, I. Fietze, M. John, M. Fleischhacker, C. Witt (Berlin, Germany)
| |